London South East | The UK's favourite investor portal.

Cont.

3. Clinical Trials (Patient Recruitment, Retention, and Adherence) For clinical trials, the Trellus Health platform can help J&J recruit patients more effectively and ensure better retention and adherence to treatment protocols, reducing costs associated with delays and inefficiencies in trials.

Example Calculation:

Average Clinical Trial Cost: Clinical trials cost anywhere from $1 million to $5 million per patient depending on the phase and type of trial.

Number of Patients in Trials: Assume J&J conducts 50 clinical trials with 1,000 patients each.

Savings from Improved Recruitment and Retention: By using the Trellus Health platform, J&J could potentially save 20% of the total trial cost by improving recruitment and retention, as well as reducing dropout rates.

Total Savings per Trial:

5,000,000 USD per trial × 0.20 efficiency gain = 1,000,000 USD per trial

Total Savings from Clinical Trials: 50 trials × 1,000,000 per trial = 50,000,000 USD

Estimated Savings from Clinical Trials: Around $50 million in trial-related costs.

4. Telemedicine and Remote Monitoring

By leveraging telemedicine and remote monitoring capabilities, J&J can avoid unnecessary office visits and reduce associated costs such as transportation, in-person consultations, and patient time away from work.

Example Calculation:

Cost per In-Person Visit: On average, an in-person visit might cost $150 per patient.

Number of Visits: Assume each patient requires 3 visits per year.

Patients Managed: Let’s assume J&J has 100,000 patients across its therapeutic areas.

Savings from Telemedicine Adoption: If J&J could shift 50% of these visits to telemedicine (with an average reduction in cost of 50% per visit), the savings would be:

100,000 patients × 3 visits per patient × 150 per visit × 0.50 shift to telemedicine = 22,500,000 USD

100,000patients×3visits per patient×150per visit×0.50shift to telemedicine=22,500,000USD

Total Estimated Savings

Summing up the individual savings estimates:

Chronic Disease Management: $90 million

Operational Efficiencies: $7.5 million

Clinical Trials: $50 million

Telemedicine and Remote Monitoring: $22.5 million

Total Estimated Annual Savings: $170 million

Conclusion

By utilizing the Trellus Health platform, Johnson & Johnson could potentially realize $170 million in annual savings across several key areas, including chronic disease management, operational efficiencies, clinical trial optimization, and telemedicine. This is a rough estimate and would depend on the actual scale and implementation specifics, but it provides a strong indication of the potential financial impact.

Here is what AI said regarding approx. cost savings for J&J per year.

1. Chronic Disease Management (e.g., IBD, Crohn's Disease)

Trellus Health focuses on managing chronic diseases like Crohn's disease, which is part of J&J’s therapeutic portfolio. According to healthcare studies, implementing digital health platforms that provide personalized care for chronic conditions can reduce hospital admissions and readmissions by up to 30%.

Example Calculation:

Number of Patients: Let’s assume J&J manages 10,000 patients with chronic diseases.

Average Hospitalization Cost: An average hospitalization for a condition like Crohn’s disease can cost approximately $30,000 per admission (based on U.S. healthcare costs).

Hospitalization Reduction: If Trellus Health reduces readmissions by 30%, J&J would avoid around 3,000 hospital admissions (30% of 10,000).

Total Savings from Avoided Hospitalizations:

3,000 admissions × 30,000 per admission = 90,000,000 USD

Estimated Annual Savings: Around $90 million in avoided hospitalization costs.

2. Operational Efficiencies (Care Coordination and Administrative Costs)

Trellus Health can also help J&J reduce administrative costs by streamlining care coordination and leveraging data-driven tools for better decision-making. Administrative costs in healthcare (e.g., staffing, management of patient records, etc.) are significant.

Example Calculation:

Annual Administrative Cost per Patient: Let’s assume that the administrative cost per patient is about $500 (this includes care coordination, medical record keeping, etc.).

Number of Patients: For simplicity, assume J&J is managing 100,000 patients.

Efficiency Gains: By streamlining operations and using the Trellus Health platform, J&J might be able to reduce these costs by 15% (a reasonable estimate for health tech platforms).

Total Savings from Administrative Efficiencies:

100,000 patients × 500 per patient × 0.15 efficiency savings = 7,500,000 USD

Estimated Annual Savings: Around $7.5 million from reduced administrative costs.

Last month Hellenic Minerals SA changed their legal status from a Private Capital Company to a Limited Liability Company. A complicated and costly process often a precursor to a major transaction.

Since the 1980’s, 199 holes have been drilled on the Molaoi acreage, each one hitting mineralisation, often with many lodes being intersected. A number of holes in the 80’s were drilled to the north well away from the 2km strike zone, these were drilled as a means of defining the size of the strike, these also struck mineralisation. To date, every hole drilled by either IGME or Rockfire has hit zinc and other associate metals, not a single miss. It is fair to say if the price of zinc had not been too volatile back in the 80’s this area would have already been asset stripped. So far Rockfire have only drilled 20 holes and this small campaign resulted in a 500% resource upgrade.

“The Chinese aren’t even offering germanium overseas now,” said Terence Bell, manager of Vancouver-based Strategic Metal Investments, a minor metals trader. Each shipment requires approval, which takes 30 to 80 days and makes long-term supply contracts unviable due to uncertainty. Markus Roas, a metals business manager at Indium Corporation, said that U.S. companies were finding it challenging to get licenses and only had weeks' worth of germanium and gallium left.

Rockfire Resources plc, which manages the deposit through its subsidiary Hellenic Minerals SA, announced a few days ago the increase of the potential reserve potential by 500% in the zinc, silver and lead deposit of the Molao Lakonia public mining area. Calculations have been made in accordance with the current Australian Joint Committee on Mineral Reserves Code for the reporting of mineral resource and ore reserve research results (JORC 2012). As a result, Molai is now among the top 20 developing zinc deposits worldwide in terms of reserve potential, grade and zinc equivalent metal content.

Speaking at the RawMat 2023 Conference, on the topic of "Critical Raw Materials: The Country's Strategic Autonomy", he pointed out that "according to official statements by the company (Rockfire), the rare, critical metal germanium (Ge), with many uses in high technology, has been found, while its inclusion in a European funding program is planned soon." According to Alexandra Sdoukou, the time has come for Greece to proceed immediately with more specific actions, with the ultimate goal of achieving the country's strategic autonomy, but also contributing to Europe's self-sufficiency in critical raw materials, to the extent that this is feasible.

Latest Share Chat

Member Info for 5085

Followers

Following

Posts (Last 30 Days)

Posts (All Time)

Last Post

Member Since

Share Chat Post Distribution (Last 30 Days)

Activity Log (Last 30 Days)